Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Binge Eating DisorderObesity
Interventions
DRUG

Lamotrigine

25 mg or 100 mg

DRUG

placebo

identical tablets to study drug

Trial Locations (1)

45040

Lindner Center of HOPE, Mason

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER